MyMichigan Medical Center Midland
Midland, Michigan, United States
Hospital in Midland, Michigan
4000 Wellness Dr, Midland, MI 48670
324 Beds
About MyMichigan Medical Center Midland
MidMichigan Medical Center-Midland is a 324-bed, non-profit hospital in Midland, Michigan. It is a member of MidMichigan Health, an integrated health delivery system affiliated with Michigan Medicine, the health care division of the University of Michigan.
There are 324 beds in MyMichigan Medical Center Midland.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
18
Boston Scientific Corporation
1
ECOG-ACRIN Cancer Research Group
1
Pfizer
1
Clinical Trials at MyMichigan Medical Center Midland
During the past decade, MyMichigan Medical Center Midland conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on
average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
2008-05-15
Active, not recruiting
394
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
2008-10-13
2017-06-15
Completed
799
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
2009-05-15
Active, not recruiting
454
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MyMichigan Medical Center Midland"
#1 collaborator was "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at MyMichigan Medical Center Midland
According to Clinical.Site data, the most researched conditions in "MyMichigan Medical Center Midland" are
"Recurrent Breast Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "MyMichigan Medical Center Midland" in a lesser frequency.
Clinical Trials Intervention Types at MyMichigan Medical Center Midland
Most popular intervention types in "MyMichigan Medical Center Midland" are "Other" (19 trials), "Drug" (17 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (7 trials), "Paclitaxel" (6 trials), "Questionnaire Administration" (6 trials) and "Bevacizumab" (5 trials). Other intervention names were less common.
Clinical Trials Genders at MyMichigan Medical Center Midland
The vast majority of trials in "MyMichigan Medical Center Midland" are
16 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at MyMichigan Medical Center Midland
Currently, there are NaN active trials in "MyMichigan Medical Center Midland".
undefined are not yet recruiting,
4 are recruiting,
15 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MyMichigan Medical Center Midland,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MyMichigan Medical Center Midland, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".